GLP-1 DRUGS
Feb 2024
Pew Research — How Americans View Weight-Loss Drugs
Predicting public opinion on GLP-1 drugs across demographic and partisan segments.
For this backtest, Intera builds a synthetic U.S. adult population calibrated to the demographic profile in the Pew survey on weight-loss drugs, including age, gender, income, and region, plus self-reported party identification. The model is asked, before seeing results, to predict support, concern, and willingness to try GLP-1 medications for weight loss by segment. Predicted response distributions are then compared to observed survey opinion to evaluate whether the synthetic population captures the right directional shifts across partisan and demographic lines.
Source: Pew Research Center, Feb 26, 2024